Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
J Neuroimmunol. 2021 Jul 15;356:577599. doi: 10.1016/j.jneuroim.2021.577599. Epub 2021 May 4.
J Neuroimmunol. 2021.
PMID: 34000472
Free PMC article.
Review.
COVID-19 vaccination is recommended for multiple sclerosis patients. Disease-modifying therapies can influence the safety and efficacy of COVID-19 vaccines. RNA, DNA, protein, and inactivated vaccines are likely safe for multiple sclerosis patie …
COVID-19 vaccination is recommended for multiple sclerosis patients. Disease-modifying therapies can influence the safety and …